Health ❯ Medicine

Patient Care

Treatment Options Medication Adherence Treatment Efficacy Personalized Medicine Cancer Treatment Rehabilitation Cancer Patients Quality of Life Treatment Outcomes Post-Operative Care Post-Operative Recovery Recovery Infections Prescription Access Surgery Volunteers in Research Cancer Treatment Strategies Diagnosis Adverse Effects Risk Reduction Treatment Protocols Counseling Socioeconomic Factors Side Effects Symptom Management Home Treatment Medication Management Post-Transplant Care Case Studies Transplant Recipient Care Cancer Screening Family Impact Life Expectancy Treatment Resistance Nutritional Recommendations Patient Experience Medication Discontinuation

Pharvaris’ Oral HAE Drug Deucrictibant Delivers Rapid Relief in Pivotal Phase 3

The company aims to file for FDA approval in the first half of 2026.

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

HSF1-Driven Autophagy Found to Undercut Proteasome Drugs in AML, Preclinical Combo Shows Benefit

Regeneron’s Garetosmab Slashes New Bone Lesions in FOP Phase 3, U.S. Filing Planned This Year

Study Links THC in Ovarian Follicles to Lower Rate of Normal Embryos in IVF

Liraglutide Cuts Chronic Migraine Days by More Than Half

Long-Term Desogestrel Use Linked to Slight Rise in Brain Tumor Risk

JM2 Peptide Disrupts Glioblastoma Stem Cells and Slows Tumor Growth in Preclinical Models

FDA Warns of Rare Severe Itching After Stopping Common Allergy Medications